You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
Test considerations for performing platelet and leukocyte count assays for in vitro hemocompatibility assessment of blood-contacting materials per ASTM F2888-19 standard
Benchmark data on CFD and blood damage validation studies sponsored by the U.S. Food & Drug Administration, and funded by the FDA’s Critical Path Initiative is available here.